Global (United States, European Union and China) Oncolytic Virus Market Research Report 2019-2025

1 Oncolytic Virus Market Overview

• 1.1 Product Overview and Scope of Oncolytic Virus
• 1.2 Oncolytic Virus Segment by Type
  • 1.2.1 Global Oncolytic Virus Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Imlygic
  • 1.2.3 Oncorine
  • 1.2.4 Others
• 1.3 Oncolytic Virus Segment by Application
  • 1.3.1 Oncolytic Virus Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Melanoma
  • 1.3.3 Other Cancers
• 1.4 Global Oncolytic Virus Market Size Estimates and Forecasts
  • 1.4.1 Global Oncolytic Virus Revenue 2015-2026
  • 1.4.2 Global Oncolytic Virus Sales 2015-2026
  • 1.4.3 Oncolytic Virus Market Size by Region: 2020 Versus 2026
• 1.5 Oncolytic Virus Industry
• 1.6 Oncolytic Virus Market Trends

2 Global Oncolytic Virus Market Competition by Manufacturers

• 2.1 Global Oncolytic Virus Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Oncolytic Virus Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Oncolytic Virus Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Oncolytic Virus Manufacturing Sites, Area Served, Product Type
• 2.5 Oncolytic Virus Market Competitive Situation and Trends
  • 2.5.1 Oncolytic Virus Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Oncolytic Virus Players (Opinion Leaders)

3 Oncolytic Virus Retrospective Market Scenario by Region

• 3.1 Global Oncolytic Virus Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Oncolytic Virus Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Oncolytic Virus Market Facts & Figures by Country
  • 3.3.1 North America Oncolytic Virus Sales by Country
  • 3.3.2 North America Oncolytic Virus Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Oncolytic Virus Market Facts & Figures by Country
  • 3.4.1 Europe Oncolytic Virus Sales by Country
  • 3.4.2 Europe Oncolytic Virus Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Oncolytic Virus Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Oncolytic Virus Sales by Region
  • 3.5.2 Asia Pacific Oncolytic Virus Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Oncolytic Virus Market Facts & Figures by Country
  • 3.6.1 Latin America Oncolytic Virus Sales by Country
  • 3.6.2 Latin America Oncolytic Virus Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Oncolytic Virus Sales by Country
  • 3.7.2 Middle East and Africa Oncolytic Virus Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Oncolytic Virus Historic Market Analysis by Type

• 4.1 Global Oncolytic Virus Sales Market Share by Type (2015-2020)
• 4.2 Global Oncolytic Virus Revenue Market Share by Type (2015-2020)
• 4.3 Global Oncolytic Virus Price Market Share by Type (2015-2020)
• 4.4 Global Oncolytic Virus Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Oncolytic Virus Historic Market Analysis by Application

• 5.1 Global Oncolytic Virus Sales Market Share by Application (2015-2020)
• 5.2 Global Oncolytic Virus Revenue Market Share by Application (2015-2020)
• 5.3 Global Oncolytic Virus Price by Application (2015-2020)

6 Company Profiles and Key Figures in Oncolytic Virus Business

• 6.1 Amgen
  • 6.1.1 Corporation Information
  • 6.1.2 Amgen Description, Business Overview and Total Revenue
  • 6.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Amgen Products Offered
  • 6.1.5 Amgen Recent Development
• 6.2 Oncolytics Biotech
  • 6.2.1 Oncolytics Biotech Corporation Information
  • 6.2.2 Oncolytics Biotech Description, Business Overview and Total Revenue
  • 6.2.3 Oncolytics Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Oncolytics Biotech Products Offered
  • 6.2.5 Oncolytics Biotech Recent Development
• 6.3 Viralytics
  • 6.3.1 Viralytics Corporation Information
  • 6.3.2 Viralytics Description, Business Overview and Total Revenue
  • 6.3.3 Viralytics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Viralytics Products Offered
  • 6.3.5 Viralytics Recent Development
• 6.4 Transgene SA
  • 6.4.1 Transgene SA Corporation Information
  • 6.4.2 Transgene SA Description, Business Overview and Total Revenue
  • 6.4.3 Transgene SA Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Transgene SA Products Offered
  • 6.4.5 Transgene SA Recent Development
• 6.5 Oncolys BioPharma
  • 6.5.1 Oncolys BioPharma Corporation Information
  • 6.5.2 Oncolys BioPharma Description, Business Overview and Total Revenue
  • 6.5.3 Oncolys BioPharma Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Oncolys BioPharma Products Offered
  • 6.5.5 Oncolys BioPharma Recent Development
• 6.6 Targovax
  • 6.6.1 Targovax Corporation Information
  • 6.6.2 Targovax Description, Business Overview and Total Revenue
  • 6.6.3 Targovax Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Targovax Products Offered
  • 6.6.5 Targovax Recent Development
• 6.7 PsiOxus Therapeutics
  • 6.6.1 PsiOxus Therapeutics Corporation Information
  • 6.6.2 PsiOxus Therapeutics Description, Business Overview and Total Revenue
  • 6.6.3 PsiOxus Therapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 PsiOxus Therapeutics Products Offered
  • 6.7.5 PsiOxus Therapeutics Recent Development
• 6.8 SillaJen Biotherapeutics
  • 6.8.1 SillaJen Biotherapeutics Corporation Information
  • 6.8.2 SillaJen Biotherapeutics Description, Business Overview and Total Revenue
  • 6.8.3 SillaJen Biotherapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 SillaJen Biotherapeutics Products Offered
  • 6.8.5 SillaJen Biotherapeutics Recent Development
• 6.9 Sorrento Therapeutics
  • 6.9.1 Sorrento Therapeutics Corporation Information
  • 6.9.2 Sorrento Therapeutics Description, Business Overview and Total Revenue
  • 6.9.3 Sorrento Therapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Sorrento Therapeutics Products Offered
  • 6.9.5 Sorrento Therapeutics Recent Development
• 6.10 Lokon Pharma
  • 6.10.1 Lokon Pharma Corporation Information
  • 6.10.2 Lokon Pharma Description, Business Overview and Total Revenue
  • 6.10.3 Lokon Pharma Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Lokon Pharma Products Offered
  • 6.10.5 Lokon Pharma Recent Development
• 6.11 Genelux Corporation
  • 6.11.1 Genelux Corporation Corporation Information
  • 6.11.2 Genelux Corporation Oncolytic Virus Description, Business Overview and Total Revenue
  • 6.11.3 Genelux Corporation Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.11.4 Genelux Corporation Products Offered
  • 6.11.5 Genelux Corporation Recent Development
• 6.12 Vyriad
  • 6.12.1 Vyriad Corporation Information
  • 6.12.2 Vyriad Oncolytic Virus Description, Business Overview and Total Revenue
  • 6.12.3 Vyriad Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.12.4 Vyriad Products Offered
  • 6.12.5 Vyriad Recent Development
• 6.13 TILT Biotherapeutics
  • 6.13.1 TILT Biotherapeutics Corporation Information
  • 6.13.2 TILT Biotherapeutics Oncolytic Virus Description, Business Overview and Total Revenue
  • 6.13.3 TILT Biotherapeutics Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.13.4 TILT Biotherapeutics Products Offered
  • 6.13.5 TILT Biotherapeutics Recent Development
• 6.14 Cold Genesys
  • 6.14.1 Cold Genesys Corporation Information
  • 6.14.2 Cold Genesys Oncolytic Virus Description, Business Overview and Total Revenue
  • 6.14.3 Cold Genesys Oncolytic Virus Sales, Revenue and Gross Margin (2015-2020)
  • 6.14.4 Cold Genesys Products Offered
  • 6.14.5 Cold Genesys Recent Development

7 Oncolytic Virus Manufacturing Cost Analysis

• 7.1 Oncolytic Virus Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Oncolytic Virus
• 7.4 Oncolytic Virus Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Oncolytic Virus Distributors List
• 8.3 Oncolytic Virus Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Oncolytic Virus Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Oncolytic Virus by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Oncolytic Virus by Type (2021-2026)
• 10.2 Oncolytic Virus Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Oncolytic Virus by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Oncolytic Virus by Application (2021-2026)
• 10.3 Oncolytic Virus Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Oncolytic Virus by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Oncolytic Virus by Region (2021-2026)
• 10.4 North America Oncolytic Virus Estimates and Projections (2021-2026)
• 10.5 Europe Oncolytic Virus Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Oncolytic Virus Estimates and Projections (2021-2026)
• 10.7 Latin America Oncolytic Virus Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Oncolytic Virus Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List